PRICE T ROWE ASSOCIATES INC /MD/ - ENCOMPASS HEALTH CORP ownership

ENCOMPASS HEALTH CORP's ticker is EHC and the CUSIP is 29261A100. A total of 414 filers reported holding ENCOMPASS HEALTH CORP in Q2 2021. The put-call ratio across all filers is 0.22 and the average weighting 0.2%.

Quarter-by-quarter ownership
PRICE T ROWE ASSOCIATES INC /MD/ ownership history of ENCOMPASS HEALTH CORP
ValueSharesWeighting
Q3 2023$4,758
+45.3%
70,826
+46.5%
0.00%
Q2 2023$3,274
+26.1%
48,342
+0.7%
0.00%
Q1 2023$2,597
-14.0%
48,000
-4.9%
0.00%
Q4 2022$3,019
-99.9%
50,472
-0.9%
0.00%
Q3 2022$2,304,000
-1.2%
50,925
+22.4%
0.00%
Q2 2022$2,332,000
-18.4%
41,598
+3.5%
0.00%
Q1 2022$2,857,000
+15.3%
40,184
+5.9%
0.00%
Q4 2021$2,477,000
-11.7%
37,955
+1.5%
0.00%
Q3 2021$2,805,000
-3.5%
37,383
+0.3%
0.00%
Q2 2021$2,907,000
-11.5%
37,255
-7.1%
0.00%
Q1 2021$3,283,000
-89.2%
40,086
-89.1%
0.00%
-100.0%
Q4 2020$30,413,000
-4.4%
367,796
-24.9%
0.00%
-25.0%
Q3 2020$31,824,000
-8.8%
489,753
-13.1%
0.00%0.0%
Q2 2020$34,884,000
-15.2%
563,275
-12.3%
0.00%
-42.9%
Q1 2020$41,114,000
-7.9%
642,092
-0.3%
0.01%
+16.7%
Q4 2019$44,623,000
+9.7%
644,196
+0.2%
0.01%0.0%
Q3 2019$40,693,000
-1.0%
643,067
-0.8%
0.01%0.0%
Q2 2019$41,091,000
+8.1%
648,530
-0.4%
0.01%0.0%
Q1 2019$38,013,000
-4.9%
650,906
+0.5%
0.01%
-14.3%
Q4 2018$39,974,000
-33.3%
647,879
-15.7%
0.01%
-22.2%
Q3 2018$59,930,000
+79.8%
768,820
+56.2%
0.01%
+80.0%
Q2 2018$33,337,000
+40.0%
492,284
+18.2%
0.01%
+25.0%
Q1 2018$23,819,000416,6350.00%
Other shareholders
ENCOMPASS HEALTH CORP shareholders Q2 2021
NameSharesValueWeighting ↓
Copeland Capital Management, LLC 569,048$28,117,0001.78%
Kalos Management, Inc. 76,118$3,761,0001.77%
Bridge City Capital, LLC 30,231$1,494,0001.08%
DALTON GREINER HARTMAN MAHER & CO 331,823$16,395,0000.86%
Horrell Capital Management, Inc. 28,641$1,415,0000.74%
Polianta Ltd 26,600$1,314,0000.43%
GLOBEFLEX CAPITAL L P 30,177$1,491,0000.42%
CARILLON TOWER ADVISERS, INC. 768,748$37,984,0000.40%
EAGLE ASSET MANAGEMENT INC 1,070,271$53,001,0000.29%
S. R. Schill & Associates 8,108$401,0000.25%
View complete list of ENCOMPASS HEALTH CORP shareholders